Endologix Hopes Nellix Deal Is A Winning Hand
Executive Summary
AAA company Endologix Inc. is carving a niche for itself in the crowded endovascular aneurysm repair field with two new products. It has developed a method of delivering aortic aneurysm grafts through a percutaneous opening, but the company’s larger opportunity might lie in a piece of technology acquired three years ago – the Nellix Endovascular Aneurysm Sealing system.
You may also be interested in...
News Briefs: Illumina Genomics Incubator; Invacare Plant Closure; New Products
Illumina launches incubator for next-gen sequencing. Invacare will close a Canada manufacturing facility. New products from Tryton, Endologix and Cook. More news.
EVAR Update: Competitors Stake Their Ground In A High-Growth Space
The endovascular abdominal aortic aneurysm repair (EVAR) market is one of the brightest growth opportunities in the medical device arena today. As a result, the competitive landscape is heating up as several new entrants stake their claim for a share of this $1+ billion opportunity.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.